PT  - JOURNAL ARTICLE
AU  - Alexander, Lori
ED  - Stone, Gregg
TI  - Hyporesponsiveness to Clopidogrel Does Not Predict 1-Year Mortality
DP  - 2012  01
TA  - MD Conference Express
PG  - 22--23
VI  - 12
IP  - 17
4099  - http://mdc.sagepub.com/content/12/17/22.short
4100  - http://mdc.sagepub.com/content/12/17/22.full
AB  - An analysis from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents [ADAPT-DES; NCT00638794] trial showed that hyporesponsiveness to clopidogrel was not independently predictive of mortality at 1-year after percutaneous coronary intervention with a drug-eluting stent. Although hyporesponsiveness to clopidogrel was associated with increased risk of stent thrombosis and myocardial infarction, it was also associated with a reduced risk of major bleeding, which has been strongly related to mortality.